EYE DROPS

摘要

The purpose of the invention is to maximize the efficacy of, minimize the incidence of side effects from, and improve the storage stability of eye drops that contain: a peptide (SSSR),the amino acid sequence of which is represented by Ser-Ser-Ser-Arg, or a pharmacologically acceptable salt thereof; and a peptide (FGLM), the amino acid sequence of which is represented by Phe-Gly-Leu-Met-NH 2 , or a pharmacologically acceptable salt thereof. The concentration ratio between the SSSR or a pharmacologically acceptable salt thereof and the FGLM or a pharmacologically acceptable salt thereof is between 1/15 and 1/50. The concentration of the SSSR or a pharmacologically acceptable salt thereof is between 0.001% and 0.3 % (w/v) and the concentration of the FGLM or a pharmacologically acceptable salt thereof is between 0.015% and 1.5% (w/V). The pH of the eye drops is maintained between 2.5 and 6.5.